Financials
- Market Capitalization 43.55 M
- Employee 12
- Founded 2001
- CEO Joel Latham
- Website www.incannex.com.au
- Headquarter Delaware, United States
- FIGI BBG01J0814Y2
- Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.16
ratio cours/chiffre d'affaires
86.42
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4183 | TLPH Talphera, Inc. - Common Stock | 1.20 USD | -2.44% | +0.84% | -9.09% | +118.18% | 62.29 M USD | ||
| 4237 | SCYX SCYNEXIS, Inc. - Common Stock | 5.37 USD | -2.72% | +4.27% | +39.12% | +554.88% | 53.43 M USD | ||
| 4361 | CPHI China Pharma Holdings, Inc. Common Stock | 0.90 USD | +1.12% | -10.00% | -22.41% | +36.14% | 38.72 M USD | ||
| 4424 | RMTI Rockwell Medical, Inc. - Common Stock | 8.17 USD | +5.42% | +2.77% | +17.39% | +327.75% | 32.93 M USD |